Current report
Open the filing on sec.gov
Veru Inc. (VERU)
Nasdaq: VERU · Pharmaceutical Preparations · Miami, FL · filing with the SEC since 1996
The companyfiscal 2024, as filed
Revenue$16.9M+3.6%
Net income-$37.8M+59.4%
Earnings per share$-2.80+74.5%
Operating cash flow-$21.7M+75.4%
Cash$24.9M+158.9%
Debtn/a
Shareholders’ equity$32.3M+64.2%
Shares, diluted13.5M+58.7%
Return on equity-124.0%
The recordfrom its filings
Filings in 202632
Newest filingSep 8 · 8-K
Annual reportDec 17, 2025
Quarterly reportAug 10, 2026
Next report due10-K by Dec 29
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents granted5
Filer categoryNon-accelerated filer<br>Smaller reporting company
Trailing twelve months to Jun 2026Net income -$13.6MCash from operations -$26.0Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
As filed, in USD. Nothing here is a forecast.
News
Insider trade report
Open the filing on sec.gov
Quarterly report
Open the filing on sec.gov
Results released
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Shelf offering
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Employee stock plan registration
Open the filing on sec.gov
Quarterly report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Nothing of this kind is on the record for this company yet.
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.